Phase II study of amrubicin (SM-5887), a novel 9-aminoanthracycline, in previously untreated patients with extensive-stage small-cell lung cancer (ES-SCLC): a trial of The West Japan Lung Cancer Group

• YOKOTA S.

収録刊行物

• 8th World Conference on Lung Cancer

  8th World Conference on Lung Cancer 1576 1997

詳細情報

• CRID: 1571135649686073984
• NII論文ID: 10008086999
• データソース種別:
  • CiNii Articles